
An #AI-derived electronic tumor marker, e19-9, demonstrated utility as a noninvasive biomarker for treatment response and prognosis among patients with #PancreaticCancer who do not produce elevated CA19-9.
ja.ma/4se03Jv

English
JAMA Surgery
18.1K posts

@JAMASurgery
JAMA Surgery is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.







































